Sonoma Pharmaceuticals
SNOA
#10862
Rank
HK$42.78 M
Marketcap
HK$8.94
Share price
-0.87%
Change (1 day)
-65.28%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -HK$19.25 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are HK$19.52 Million. In 2025 the company made an earning of -HK$21.69 Million, an increase over its 2024 earnings that were of -HK$35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$19.25 Million-11.27%
2025 -HK$21.69 Million-38.02%
2024 -HK$35 Million0.54%
2023 -HK$34.81 Million-31.5%
2022 -HK$50.82 Million16.86%
2021 -HK$43.49 Million194.32%
2020 -HK$14.78 Million-58.76%
2019 -HK$35.82 Million-65.66%
2018 -HK$0.11 Billion4.84%
2017 -HK$99.51 Million-2.17%
2016 -HK$0.11 Billion32.12%
2015 -HK$76.99 Million-307.74%
2014 HK$37.05 M-197.5%
2013 -HK$38.01 Million
2010 -HK$59.4 Million-14.02%
2009 -HK$69.08 Million-57.28%
2008 -HK$0.17 Billion-8.03%
2007 -HK$0.18 Billion3.85%
2006 -HK$0.17 Billion39.31%
2005 -HK$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$1.8 Billion 9,202.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion 637.75%๐Ÿ‡บ๐Ÿ‡ธ USA